Page last updated: 2024-10-20

pqq cofactor and Cardiovascular Stroke

pqq cofactor has been researched along with Cardiovascular Stroke in 3 studies

PQQ Cofactor: A pyrrolo-quinoline having two adjacent keto-groups at the 4 and 5 positions and three acidic carboxyl groups. It is a coenzyme of some DEHYDROGENASES.
pyrroloquinoline quinone : A pyrroloquinoline having oxo groups at the 4- and 5-positions and carboxy groups at the 2-, 7- and 9-positions.

Research Excerpts

ExcerptRelevanceReference
"Metoprolol and/or PQQ were given at the onset of reperfusion to mimic clinical treatment."1.33Comparison of pyrroloquinoline quinone and/or metoprolol on myocardial infarct size and mitochondrial damage in a rat model of ischemia/reperfusion injury. ( Cecchini, G; Karliner, JS; Li, L; Simonis, U; Teerlink, JR; Zhou, HZ; Zhu, BQ, 2006)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bauerly, K1
Harris, C1
Chowanadisai, W1
Graham, J1
Havel, PJ1
Tchaparian, E1
Satre, M1
Karliner, JS3
Rucker, RB1
Zhu, BQ2
Zhou, HZ2
Teerlink, JR2
Simonis, U1
Cecchini, G1
Li, L1

Other Studies

3 other studies available for pqq cofactor and Cardiovascular Stroke

ArticleYear
Altering pyrroloquinoline quinone nutritional status modulates mitochondrial, lipid, and energy metabolism in rats.
    PloS one, 2011, Volume: 6, Issue:7

    Topics: Animals; Body Weight; Diabetes Mellitus, Type 2; Disease Models, Animal; Energy Metabolism; Glucose;

2011
Pyrroloquinoline quinone (PQQ) decreases myocardial infarct size and improves cardiac function in rat models of ischemia and ischemia/reperfusion.
    Cardiovascular drugs and therapy, 2004, Volume: 18, Issue:6

    Topics: Animals; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Function Tests

2004
Comparison of pyrroloquinoline quinone and/or metoprolol on myocardial infarct size and mitochondrial damage in a rat model of ischemia/reperfusion injury.
    Journal of cardiovascular pharmacology and therapeutics, 2006, Volume: 11, Issue:2

    Topics: Adrenergic beta-Antagonists; Animals; Antioxidants; Body Weight; Cardiotonic Agents; Creatine Kinase

2006